The Economics of Effective AIDS Treatment: Policy Evaluation for Thailand

A policy evaluation report advising the Thai government on the costs and benefits of expanding public antiretroviral therapy (ART) through the National Access to Antiretroviral Program for People Living with HIV/AIDS (NAPHA). The study, authored by Ana Revenga, models several policy options, finding the NAPHA program with a first-line regimen to be the most cost-effective. It also evaluates the impact of enhanced policies like early patient recruitment and improved adherence.

Use Cases

• Modeling the cost-effectiveness of public health programs based on the described policy scenarios for ART.
• Evaluating the financial sustainability of national HIV/AIDS treatment programs based on the described model assumptions.
• Analyzing the impact of patient adherence and early recruitment on treatment outcomes based on the suggested enhanced policies.
• Assessing the sensitivity of government health expenditures to pharmaceutical intellectual property agreements as mentioned in the findings.

Strengths

• Report provides specific, modeled findings on the cost-effectiveness of Thailand's NAPHA program.
• Analysis compares multiple policy options, including first-line therapy, second-line therapy, and enhanced adherence strategies.

Limitations

• Row count and column-level documentation are absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.
• Data may reflect a modeling bias inherent to the specific economic analysis described.

Provenance

Source

Ana Revenga

Collection Method

Likely contains results from an economic modeling study, as described.

Geography

Thailand